TORONTO, ON / ACCESS Newswire / September 9, 2025 / Helix BioPharma Corp. (TSX:HBP)(OTC:HBPCF)(FRANKFURT:HBP0) ("Helix" or the "Company"), a clinical-stage…
Black Book Mid Year Update on Irish Health IT Adoption and Vendor Performance DUBLIN, IE / ACCESS Newswire / September…
HORGEN, Switzerland, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Numab Therapeutics AG (“Numab”), a biotechnology company advancing a proprietary pipeline of…
Phase 1 data for efarindodekin alfa (XTX301) demonstrate promising anti-tumor activity in patients with advanced solid tumors Achievement of milestone…
Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular…
WALNUT CREEK, Calif., Sept. 8, 2025 /PRNewswire/ -- Vantiq, the leading global platform for building and operating intelligent systems in real-time,…
TransformativeMed Now Positioned as Go-To Platform for Intelligent Systems and AI leadership SEATTLE, Sept. 8, 2025 /PRNewswire/ -- TransformativeMed, the…
Increasing number of hospitals adopting AI-driven Quippe to improve clinical documentation and clinical decision support HERNDON, Va., Sept. 8, 2025…
Data found 12 times higher risk of turnover among nonresponding clinicians, revealing how nonresponse bias distorts survey results and emphasizing…